Abstract
The differences in the pharmacokinetics of cefotaxime, moxalactam, and CPW 86-363, a new expanded-spectrum cephalosporin, were studied in healthy rabbits and in rabbits infected intravenously with Streptococcus pneumoniae. The pharmacokinetic analysis of concentration-time courses in the sera of infected animals according to a two compartment-model evidenced a clear decrease of drug fractions in the central compartment but enhanced drug fractions in the peripheral compartment. The shift was more pronounced in animals which received CPW 86-363 (60%; P less than 0.05) than in those which received cefotaxime (20%) or moxalactam (5%). Corresponding increases in drug concentration were observed in soft tissue interstitial fluid; therefore, the areas under the curve and mean residence times in the soft tissue interstitial fluid of infected rabbits were prolonged. The shift of drug fractions from the central compartment to other body fluid compartments during infection was thought to be due to cardiovascular changes associated with fever. No changes in serum binding of the three drugs were found during the course of the infection. The quantitative differences in the extent of altered distribution properties of the drugs might be due to variations in the physicochemical properties of the drugs.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arret B., Johnson D. P., Kirshbaum A. Outline of details for microbiological assays of antibiotics: second revision. J Pharm Sci. 1971 Nov;60(11):1689–1694. doi: 10.1002/jps.2600601122. [DOI] [PubMed] [Google Scholar]
- Barre J., Houin G., Brunner F., Bree F., Tillement J. P. Disease-induced modifications of drug pharmacokinetics. Int J Clin Pharmacol Res. 1983;3(4):215–226. [PubMed] [Google Scholar]
- DOST F. H. Uber ein einfaches statistisches Dosis-Umsatz-Gesetz. Klin Wochenschr. 1958 Jul 15;36(14):655–657. doi: 10.1007/BF01488743. [DOI] [PubMed] [Google Scholar]
- Goldblum S. E., Reed W. P. Effect of intravascular pneumococcal challenge on vascular permeability in rabbits. J Infect Dis. 1983 Jul;148(1):179–179. doi: 10.1093/infdis/148.1.179. [DOI] [PubMed] [Google Scholar]
- Gomeni R. PHARM--an interactive graphic program for individual and population pharmacokinetic parameter estimation. Comput Biol Med. 1984;14(1):25–34. doi: 10.1016/0010-4825(84)90017-9. [DOI] [PubMed] [Google Scholar]
- Laber G., Schütze E., Leskova R., Kolb R., Georgopoulos A. A diffusion chamber technique for measuring concentrations of antibiotics in interstitial fluid. Infection. 1980;8(2):58–62. doi: 10.1007/BF01639147. [DOI] [PubMed] [Google Scholar]
- Perfect J. R., Durack D. T. Pharmacokinetics of cefoperazone, moxalactam, cefotaxime, trimethoprim and sulphamethoxazole in experimental meningitis. J Antimicrob Chemother. 1981 Jul;8(1):49–58. doi: 10.1093/jac/8.1.49. [DOI] [PubMed] [Google Scholar]
- Rosenberg I. K. Renal hemodynamic effects of sepsis. Heart Lung. 1976 Sep-Oct;5(5):777–780. [PubMed] [Google Scholar]
- Schmook F. P., Nefzger M., Laber G., Georgopoulos A., Czok R., Schütze E. Composition of fluids from diffusion chambers implanted in the soft tissue and kidneys of rabbits. Infection. 1980;8(4):156–161. doi: 10.1007/BF01639123. [DOI] [PubMed] [Google Scholar]
- Tognoni G., Bellantuono C., Bonati M., D'Incalci M., Gerna M., Latini R., Mandelli M., Porro M. G., Riva E. Clinical relevance of pharmacokinetics. Clin Pharmacokinet. 1980 Mar-Apr;5(2):105–136. doi: 10.2165/00003088-198005020-00001. [DOI] [PubMed] [Google Scholar]